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This paper presents a case of rhinocerebral mucormycosis in a 22-year-old female patient with type I diabetes mellitus, who was
successfully treated with surgery and long-term antifungal medication. The patient had initially been submitted to extraction of an
upperthirdmolarby a general dental practitioner butwas referred toourdepartment threedays postoperatively becauseof double
vision. Immediately following histopathological conﬁrmation of the infection, the patient was administered Amphotericin B and
Posaconazole intravenously. Surgical excision of the aﬀected site was relatively conservative. The patient was free of the disease 15
months after initial admission to the hospital and has recently returned for reconstruction. The aim of this paper is to increase
the awareness of general dental practitioners regarding uncommon serious conditions in diabetic patients, which may be confused
with periodontal or dental diseases.
1.Introduction
Mucormycosis is a rare and potentially lethal infection. It is
causedbyfungi,whichmaybefoundindecayingfood,inthe
soil, or other organic matter, such as animal excreta [1].
Immunocompromisedpatientsareespeciallysusceptible,
and timely diagnosis as well as intervention are of utmost
importance for successful management. Because of atypical
initial symptoms, such as facial pain, earache, sinus pain,
or odontalgia, patients may seek dental treatment initially.
Dental care may also precede such an infection, by means
of a creation of a postextraction or postcurretage wound,
which may be susceptible to fungal infection [2]. The aim
of this case report is to present a patient with rhinocerebral
mucormycosis who was successfully treated due to timely
diagnosis, eﬀective surgical intervention, and intravenous
antifungal treatment.
2.CaseReport
A 22-year-old woman was transferred to the Oral and
Maxillofacial Department for facial pain, oedema, and
double vision, following extraction of the upper right third
molar tooth three days earlier. The patient had initially
visited an ear-nose-throat specialist because of diﬀuse pain
of the midface a week previously. They had recommended a
dental examination of the upper right molars and premolars.
The general dental practitioner had decided to extract the
patient’s upper right third molar tooth, which was in close
contact to the inferior wall of the maxillary sinus, assuming
that the symptoms were odontogenic.
The general dental practitioner had prescribed amoxi-
cillin postoperatively and advised on oral hygiene. However,
the pain had gradually deteriorated after the extraction. The
patient had been hospitalized for generalized facial oedema
and pain in a regional hospital but was transferred to our
institution twenty-four hours later, when she developed
double vision due to paralysis of the right lateral rectus
muscle. The patient’s medical history included diabetes
mellitus type I, which was poorly controlled. On clinical
examination, she presented slight hemifacial oedema of the
right side, inward gaze of the right eye because of paralysis
of the abduscent nerve (VI cranial nerve), as can be seen
in Figures 1 and 2. Neurological examination also revealed2 International Journal of Dentistry
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hypaesthesiaoftheareaofdistributionofthemaxillarynerve
(2nd branch of the V cranial nerve). The right side of the
palatewasredwithanulcerof1cmdiameter,nearthesecond
upper molar tooth (Figure 3).
Generally, the patient was an undernourished young
woman, with normal vital signs, and unwilling to provide
information regarding her diabetes or the reason for den-
tal care. Undertaken investigations at admittance included
blood count, serum electrolytes,urea, kreatinin, glucose, and
C-reactive protein. These revealed elevated blood glucose
and mild dehydration. Furthermore, glycated haemoglobin
(glycohemoglobin, HbA1c) was raised to 12.3%, with the
normal range between 4–5.9% (Table 1). Opthalmological
examination showed palpebral oedema of the right side, no
lesions of the retina or optic nerve, but diplopia at the right
outward gaze, which conﬁrmed the paralysis of the right
lateral rectus muscle.
Figure 3
Table 1
Laboratory ﬁndings Initial values Final values
Blood glucose (mg/dL) 197 110
Glycated haemoglobin (%) 12.3 5
CRP (mg/dL) 20.01 1
WBC (×103) 9.47 5.14
Hemoglobin (g/dL) 10.3 12.4
Hematocrit (%) 25.8 37
Computerised tomography revealed thickening of the
mucosal lining of the paranasal sinuses. Further imaging
with magnetic resonance imaging also showed involvement
of all paranasal sinuses of the right side, however, without
involvement of the central nervous system (Figure 4). A
biopsy of the palatal ulcer showed fungal infection by species
of Mucorales (Figure 5). The patient was initiated with
intravenous antifungal agents (amphotericin B 300mg qd
and posaconazole 200mg tid), and three days later she
underwent subtotal right maxillectomy and reconstruction
with an obturator. Thereafter, she continued the antifungal
treatment, presenting gradual improvement. The paralysis
of the right lateral rectus muscle progressively recovered, so
the patient was dismissed from the hospital 2 months later,
free of any infection, and has recently returned for deﬁnitive
reconstruction (Figure 6). During her hospitalization, our
patient was also accustomed to more eﬀective blood glucose
management (Table 1).
3. Discussion
The species of Mucorales invade blood vessels and cause
necrosis of vessel walls and mycotic thrombi. While healthy
humans are resistant to such an infection, immunocom-
promised patients are generally much more vulnerable to
the angioinvasive hyphal forms of these fungi [1]. Diabetes
mellitus, neutropenia, severe trauma, immunosuppression
following transplantation of bone marrow, or solid organs
are all predisposing factors for mucormycosis [1, 3, 4].
The host-speciﬁc condition may however render the host
susceptible to diﬀerent types of the infection.International Journal of Dentistry 3
Figure 4
Mucormycosis is classiﬁed according to the anatomic
site of occurrence in (1) rhinocerebral, (2) pulmonary, (3)
cutaneous, (4) gastrointestinal, and (5) disseminated [5].
Rhinocerebral or sino-orbital types are common among
diabetic patients, especially those who are poorly controlled.
The above-mentioned types of infection may present with
various and atypical symptoms of sinusitis [1, 6]. Nasal
congestion, headache, earache, or facial pain are some of the
most common features, which are not at all characteristic.
Depending on the aﬀected site, adjacent structures like
the orbit or the central nervous system may be involved.
Periorbital edema, ophthalmoplegia, or deterioration of
vision is of high probability. Similarly, extension to the
cavernoussinus may cause cavernoussinus thrombosis [1, 2]
or aﬀect cranial nerves. Through the cribriform plate of the
ethmoid bone or the supraorbital ﬁssure, the infection may
spread intracranially and cause abscesses or sagittal sinus
thrombosis [1]. Perineural invasion and spread has also been
reported [2, 7]. The aﬀected area is initially clear of any
signs, but soon may appear reddish with or without necrotic
eschars [1, 4]. Especially intraorally, the palate may present
necrotic with large black eschars. Nasal endoscopy is usually
necessary to reveal other necrotic lesions [1].
Radiographic ﬁndings are generally inconclusive and not
speciﬁc.CTandMRIarewithinnormallimitsinitially,which
are followed by signs of sinusitis, such as congested sinus
or thickened mucosal lining. Repetition of the investigations
is necessary for close followup of the advancement of the
disease. Diﬀerential diagnosis mainly includes necrotizing
fasciitis [3], especially if facial oedema is present. As the
condition rapidly aggravates, timely diagnosis is crucial.
A histopathological diagnosis is generally considered more
precise than simple culture, as the latter may be unyielding
due to the depth of invasion of the infection [1, 8, 9].
Successful management depends on timing. As soon as
the clinical suspicion has risen, it is imperative to perform
a biopsy of the area and initiate intravenous antifungal
Figure 5
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treatment [1, 2, 9]. Early intervention with ablative surgery
is generally recommended [10–14].
Especially considering rhinocerebral or rhino-orbital
mucormycosis, enucleation of the eye is contemplated as
imperative for deﬁnitive treatment. Although the Internal
Medicine faculty strongly suggested total maxillectomy and
removal of the eye, because of the aforementioned evidence,
the absence of vision disturbance, severe conjunctival infec-
tion, or even optic nerve involvement in a young patient
led to a more conservative maxillectomy. Indeed, the patient
recovered following long-term antifungal treatment.
This fact is probably due to early intervention as well
as no participation of the contents of the orbit, but cranial
nerves. However, signs of involvement of the orbital area
should always direct to a total maxillectomy, including the
globe.
The diﬀerential diagnosis of such a peculiar condition
should initially include cocaine abuse, fasciitis, or other
opportunistic infections of an immunocompromised host,
such as aspergillosis, herpes simplex, or herpes zoster.
Dental practitioners should be aware of rhinocerebral
mucormycosis, speciﬁcally in cases of diabetic and other
immunocompromised patients. Atypical symptoms such
as facial pain, sinus pain, or unexpected odontalgia of
otherwise healthy teeth should alert clinicians. Moreover,
when a patient seems to deteriorate after dental therapeutic
interventions, one should consider rare conditions, such as
mucormycosis, and promptly urge the patient to seek med-
ical advice. Particularly, meticulous intraoral examination
should be performed to all patients, as atypical lesions may
thus be revealed and estimated. In the case presented, a slight
change of the mucosal colour or dehiscence of the palate
[15] might have been noticed. Similarly, it is imperative that
all general dental practitioners note the patients’ medical
history and modify their diagnostic or therapeutic actions
accordingly. As known, a raised glycated haemoglobin level
is indicative of a poor blood glucose control by the diabetic4 International Journal of Dentistry
patient [16]. If the dentist had required a serum glucose
or glycated haemoglobin test, he might have estimated the
poorly controlled diabetic condition and might have avoided
the unnecessary extraction of the upper right third moral
tooth.Instead,amoreprecisedentalexaminationmighthave
showntheneedforfurtherinvestigationofthepatient’sfacial
pain.
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